ישראל - עברית - Ministry of Health

biovac ltd., israel - tylosin as tartrate - אבקה מסיסה - tylosin as tartrate 90.9 %w/w

ישראל - עברית - Ministry of Health

biovac ltd, israel - doxycycline as hydrochloride 100 % - powder for solution - for treatment of diseases coused by riketsia, arlichia, micoplasma, clamidia, plaasmodium, gkineseum, spirocheta and other bacteria sensitive to tetracyclines in turkeys.

ישראל - עברית - Ministry of Health

eliezer linevitz ltd. - marbofloxacin - תמיסה להזרקה - marbofloxacin 100 mg/ml - in cattle: treatment of respiratory infections caused by sensitive strains of pasteurella multocida, pasteurella haemolytica bovis. in sows: treatment of metritis mastitis agalactia syndrome caused by bacterial strains sensitive to marbofloxacin treatment in both species should be given only after the sensitivity of the bacteria has been proven and it has been found that there is no alternative treatment (proven resistance to other agents).

ישראל - עברית - Ministry of Health

m.p.vet ltd - tilmicosin - תמיסה - tilmicosin 250 mg ml - for the treatment of respiratory infections in chicken flocks associated with mycoplasma gallisepticum and mycoplasma synoviae when the disease has been diagnosed at the herd level.

ישראל - עברית - Ministry of Health

eliezer linevitz ltd. - marbofloxacin - תמיסה להזרקה - marbofloxacin 2 %w/v

ישראל - עברית - Ministry of Health

m.p.vet ltd - marbofloxacin - תמיסה להזרקה - marbofloxacin 100 mg / 1 ml

ישראל - עברית - Ministry of Health

romat ltd - marbofloxacin - תמיסה להזרקה - marbofloxacin 100 mg / 1 ml

ישראל - עברית - Ministry of Health

romat ltd - marbofloxacin - תמיסה להזרקה - marbofloxacin 20 mg / 1 ml

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - azithromycin - אבקה להכנת תרחיף - azithromycin 2.096 g - azithromycin - azithromycin - zmax is indicated for the treatment of patients 18 years of age and above with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. adults: acute bacterial sinusitis due to haemophilus influenzae moraxella catarrhalis or streptococcus pneumoniae. community-acquired pneumonia due to chlamydophila pneumoniae, haemophilus influenzae mycoplasma pneumoniae or streptococcus pneumoniae in patients appropriate for oral therapy.

ישראל - עברית - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - תמיסה לאינפוזיה - moxifloxacin as hydrochloride 1.6 mg/ml - moxifloxacin - moxifloxacin - megaxin iv is indicated for the treatment of adults (> 18 years of age) with community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.